Education BOE Importance: 3/10

Carlos III Health Institute extends its agreement with FEDER to evaluate rare disease research projects

08 May 2026 10 views
Who is affected:
Researchers and groups applying for research grants in rare diseases

Summary

The Carlos III Health Institute renews its agreement with the FEDER Foundation so that it evaluates applications for research grants in rare diseases.

Detailed analysis PRO

The Carlos III Health Institute publishes the addendum that modifies and extends the agreement signed with the FEDER Foundation for Research. The purpose of the agreement is for FEDER to collaborate in the evaluation of proposals submitted to the call for grants aimed at researching rare diseases. This extension ensure…

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Crear cuenta gratis Ver planes PRO

Full official title

Resolución de 28 de abril de 2026, del Instituto de Salud Carlos III, O.A., M.P., por la que se publica la Adenda de modificación y prórroga del Convenio con la Fundación FEDER para la Investigación, para realizar la evaluación de las propuestas de investigación presentadas a la convocatoria de ayudas a la investigación de enfermedades raras.

View original source (BOE)

Affected sectors

Healthcare

Categories

Tax & Revenue Labour & Employment Corporate & Business Data Protection Social Security European Regulations Grants & Subsidies Other Regulations Public Sector Education Energy Agriculture & Fisheries Real Estate

PRO Plan

Alerts, detailed analysis and private Telegram channel.

From 9.99 EUR/month

Related regulations